Artificial intelligence (AI) has emerged as a powerful technology that has the potential to transform education. This study aims to comprehensively understand students' perspectives on using AI within educational settings to gain insights about the role of AI in education and investigate their perceptions regarding the advantages, challenges, and expectations associated with integrating AI into the learning process. We analyzed the student responses from a survey that targeted students from diverse academic backgrounds and educational levels. The results show that, in general, students have a positive perception of AI and believe AI is beneficial for education. However, they are still concerned about some of the drawbacks of using AI. Therefore, it is necessary to take steps to minimize the negative impact while continuing to take advantage of the advantages of AI in education.
9 September 2023 in Indatu Journal of Management and Accounting
The rise of digital transactions and electronic payment systems in modern financial management has brought convenience but also the challenge of credit card fraud. Traditional fraud detection methods are struggling to cope with the complexities of contemporary fraud strategies. This study explores the potential of machine learning, specifically the XGBoost (eXtreme Gradient Boosting) algorithm, combined with data augmentation techniques, to enhance credit card fraud detection. The research demonstrates the effectiveness of these techniques in addressing imbalanced datasets and improving fraud detection accuracy. The study showcases a balanced approach to precision and recall in fraud detection by leveraging historical transaction data and employing techniques like Synthetic Minority Over-sampling Technique-Edited Nearest Neighbors (SMOTE-ENN). The implications of these findings for contemporary financial management are profound, offering the potential to bolster financial integrity, allocate resources effectively, and strengthen customer trust in the face of evolving fraud tactics.
This study focuses on the development of a machine learning ensemble approach for the classification of Beta-Secretase 1 (BACE1) inhibitors in Quantitative Structure-Activity Relationship (QSAR) analysis. BACE1 is an enzyme linked to the production of amyloid beta peptide, a significant component of Alzheimer's disease plaques. The discovery of effective BACE1 inhibitors is difficult, but QSAR modeling offers a cost-effective alternative by predicting the activity of compounds based on their chemical structures. This study evaluates the performance of four machine learning models (Random Forest, AdaBoost, Gradient Boosting, and Extra Trees) in predicting BACE1 inhibitor activity. Random Forest achieved the highest performance, with a training accuracy of 98.65% and a testing accuracy of 82.53%. In addition, it exhibited superior precision, recall, and F1-score. Random Forest's superior performance was a result of its ability to capture a wide variety of patterns and its randomized ensemble approach. Overall, this study demonstrates the efficacy of ensemble machine learning models, specifically Random Forest, in predicting the activity of BACE1 inhibitors. The findings contribute to ongoing efforts in Alzheimer's disease drug discovery research by providing a cost-effective and efficient strategy for screening and prioritizing potential BACE1 inhibitors.
22 August 2023 in Infolitika Journal of Data Science
Diabetes is a chronic condition characterized by elevated blood glucose levels which leads to organ dysfunction and an increased risk of premature death. The global prevalence of diabetes has been rising, necessitating an accurate and timely diagnosis to achieve the most effective management. Recent advancements in the field of machine learning have opened new possibilities for improving diabetes detection and management. In this study, we propose a fine-tuned XGBoost model for diabetes detection. We use the Pima Indian Diabetes dataset and employ a random search for hyperparameter tuning. The fine-tuned XGBoost model is compared with six other popular machine learning models and achieves the highest performance in accuracy, precision, sensitivity, and F1-score. This study demonstrates the potential of the fine-tuned XGBoost model as a robust and efficient tool for diabetes detection. The insights of this study advance medical diagnostics for efficient and personalized management of diabetes.
This study explores the use of Quantitative Structure-Activity Relationship (QSAR) studies using genetic algorithm (GA) and LightGBM to search for acetylcholinesterase (AChE) inhibitors for Alzheimer's disease. The study uses a dataset of 6,157 AChE inhibitors and their IC50 values. A LightGBM model is trained and evaluated for classification performance. The results show that the LightGBM model achieved high performance on the training and testing set, with an accuracy of 92.49% and 82.47%, respectively. This study demonstrates the potential of GA and LightGBM in the drug discovery process for AChE inhibitors in Alzheimer's disease. The findings contribute to the drug discovery process by providing insights about AChE inhibitors that allow more efficient screening of potential compounds and accelerate the identification of promising candidates for development and therapeutic use.
Hepatitis C virus (HCV) infection affects over 71 million people worldwide, leading to severe liver diseases, including cirrhosis and hepatocellular carcinoma. The virus’s high mutation rate complicates current antiviral therapies by promoting drug resistance, emphasizing the need for novel therapeutics. Traditional high-throughput screening (HTS) methods are costly, time-consuming, and prone to false positives, underscoring the necessity for more efficient alternatives. Machine learning (ML), particularly quantitative structure–activity relationship (QSAR) modeling, offers a promising solution by predicting compounds’ biological activity based on chemical structures. However, the “black-box” nature of many ML models raises concerns about interpretability, which is critical for understanding drug action mechanisms. To address this, we propose an explainable multi-model stacked classifier (MMSC) for predicting hepatitis C drug candidates. Our approach combines random forests (RF), support vector machines (SVM), gradient boosting machines (GBM), and k-nearest neighbors (KNN) using a logistic regression meta-learner. Trained and tested on a dataset of 495 compounds targeting HCV NS3 protease, the model achieved 94.95% accuracy, 97.40% precision, and a 96.77% F1-score. Using SHAP values, we provided interpretability by identifying key molecular descriptors influencing the model’s predictions. This explainable MMSC approach improves hepatitis C drug discovery, bridging the gap between predictive performance and interpretability while offering actionable insights for researchers.